As of 2024-12-12, the Relative Valuation of Allergy Therapeutics PLC (AGY.L) is (20.83) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 6.30 GBP, the upside of Allergy Therapeutics PLC based on Relative Valuation is -430.6%.
The range of the Relative Valuation is (16.51) - (24.51) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.4x - 27.6x | 15.6x |
| Forward P/E multiples | 14.9x - 22.1x | 21.9x |
| Fair Price | (16.51) - (24.51) | (20.83) |
| Upside | -362.0% - -489.0% | -430.6% |
| Date | P/E |
| 2024-12-02 | -4.77 |
| 2024-11-29 | -4.77 |
| 2024-11-28 | -4.72 |
| 2024-11-27 | -4.77 |
| 2024-11-26 | -4.77 |
| 2024-11-25 | -4.50 |
| 2024-11-22 | -4.59 |
| 2024-11-21 | -4.68 |
| 2024-11-20 | -4.95 |
| 2024-11-19 | -4.93 |
| 2024-11-18 | -4.77 |
| 2024-11-15 | -4.97 |
| 2024-11-14 | -4.95 |
| 2024-11-13 | -4.88 |
| 2024-11-12 | -5.04 |
| 2024-11-11 | -4.99 |
| 2024-11-08 | -4.86 |
| 2024-11-07 | -5.04 |
| 2024-11-06 | -4.95 |
| 2024-11-05 | -4.88 |
| 2024-11-04 | -4.95 |
| 2024-11-01 | -4.95 |
| 2024-10-31 | -4.86 |
| 2024-10-30 | -4.50 |
| 2024-10-29 | -4.77 |
| 2024-10-28 | -4.68 |
| 2024-10-25 | -4.77 |
| 2024-10-24 | -4.50 |
| 2024-10-23 | -4.50 |
| 2024-10-22 | -4.39 |
| 2024-10-21 | -4.50 |
| 2024-10-18 | -4.39 |
| 2024-10-17 | -4.28 |
| 2024-10-16 | -4.50 |
| 2024-10-15 | -3.83 |
| 2024-10-14 | -3.83 |
| 2024-10-11 | -3.83 |
| 2024-10-10 | -3.83 |
| 2024-10-09 | -3.83 |
| 2024-10-08 | -4.05 |
| 2024-10-07 | -4.37 |
| 2024-10-04 | -4.37 |
| 2024-10-03 | -4.46 |
| 2024-10-02 | -4.28 |
| 2024-10-01 | -4.14 |
| 2024-09-30 | -4.23 |
| 2024-09-27 | -4.28 |
| 2024-09-26 | -4.23 |
| 2024-09-25 | -4.24 |
| 2024-09-24 | -4.28 |